The effect of Ginkgo biloba extract on 3-nitropropionic acid-induced neurotoxicity in rats
► 3-NP induces neurodegeneration similar to that observed in HD. ► EGb 761 benefits directed us to test its effects against 3-NP-induced HD. ► Results suggest that EGb 761 has a neuroprotective role against 3-NP-induced HD. ► EGb 761 protective mechanism attributed to antioxidant and antiapoptotic e...
Gespeichert in:
Veröffentlicht in: | Neurochemistry international 2011-11, Vol.59 (6), p.770-778 |
---|---|
Hauptverfasser: | , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | ► 3-NP induces neurodegeneration similar to that observed in HD. ► EGb 761 benefits directed us to test its effects against 3-NP-induced HD. ► Results suggest that EGb 761 has a neuroprotective role against 3-NP-induced HD. ► EGb 761 protective mechanism attributed to antioxidant and antiapoptotic effects.
3-Nitropropionic acid (3-NP), an irreversible inhibitor of succinate dehydrogenase enzyme (SDH), induces neurodegeneration similar to that observed in Huntington’s disease (HD). Reduction of prepulse inhibition (PPI) of acoustic startle response, locomotor hypoactivity, bilateral striatal lesions as well as brain oxidative stress are major features of HD. The present study was designed to investigate neuroprotective effect of
Ginkgo biloba extract (EGb 761) on 3-NP induced neurobehavioral changes and striatal lesions.
Rats administered 3-NP (20
mg/kg, s.c.) for five consecutive days exhibited PPI deficits and locomotor hypoactivity whereas, pretreatment of animals with EGb 761 (100
mg/kg, i.p. for 15
days) ahead of and during the induction of HD by 3-NP (20
mg/kg for 5
days starting at day 8) ameliorated 3-NP-induced neurobehavioral deficits. Administration of 3-NP increased the level of striatal malondialdehyde (MDA). This effect was prevented in animals pre-treated with EGb 761. Changes in the level of apoptotic regulatory gene expressions, following 3-NP treatment, were demonstrated as both an up-regulation and a down-regulation of the expression levels of striatal
Bax and
Bcl-xl genes, respectively. In addition, an up-regulation of the expression level of striatal glyceraldehyde-3-phosphate dehydrogenase (
GAPDH) was also observed. Pre-treatment with EGb 761 caused a down-regulation in striatal
GAPDH and
Bax together with an up-regulation of striatal
Bcl-xl expression level as compared to the 3-NP treated group. Histochemical examination of striatal tissue showed that EGb 761 significantly prevented 3-NP induced inhibition of SDH activity. Histopathological examination further affirmed the neuroprotective effect of EGb 761 against 3-NP toxicity.
Taken together, these results suggest that EGb 761 has a neuroprotective role in the current HD paradigm, which may be related to improvement of energy metabolism, antioxidant properties and antiapoptotic effects. |
---|---|
ISSN: | 0197-0186 1872-9754 |
DOI: | 10.1016/j.neuint.2011.07.012 |